Treatments for stage 3 hypopharyngeal cancer

The following are treatment options for stage 3 hypopharyngeal cancer. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.

Surgery

Surgery is one of the main treatments for stage 3 hypopharyngeal cancer. It is used to remove the tumour along with a margin of healthy tissue around it. Surgery is the main treatment option when the cancer has made it difficult to swallow or breathe. The most common surgery used is a laryngopharyngectomy with a neck dissection. A laryngopharyngectomy removes part or all of the larynx (voice box), part or all of the pharynx (throat) and part of the esophagus. A neck dissection removes the lymph nodes in the neck (cervical lymph nodes).

Other procedures may be done to help with breathing and nutrition. These include:

  • placement of a breathing tube (called a tracheostomy) to help you breathe
  • placement of a feeding tube (usually a gastrostomy) to make sure you get enough nutrients

Surgery for hypopharyngeal cancer may affect your ability to speak and swallow. It may also affect your appearance. Reconstructive surgery is often done to improve the look and function of the mouth and neck as much as possible. It is usually done at the same time as the surgery to remove the hypopharyngeal tumour.

Chemoradiation

Chemoradiation is one of the main treatments for stage 3 hypopharyngeal cancer. In chemoradiation, chemotherapy is given during the same time period as radiation therapy. The chemotherapy makes the radiation more effective.

For stage 3 hypopharyngeal cancer, cisplatin is the chemotherapy drug given along with radiation to the tumour and lymph nodes on both sides of the neck.

Radiation therapy

External radiation therapy is one of the main treatments for stage 3 hypopharyngeal cancer. Radiation therapy is usually given during the same time period as chemotherapy (called chemoradiation). Radiation therapy or chemoradiation is given after surgery for stage 3 hypopharyngeal cancer.

Intensity-modulated radiation therapy (IMRT) is a specialized type of external radiation therapy. It may be used to lessen the damage to tissues around the tumour.

Chemotherapy

Chemotherapy may be given to shrink the tumour before surgery or radiation therapy for stage 3 hypopharyngeal cancer. The most common chemotherapy drug combination used to treat hypopharyngeal cancer is cisplatin and fluorouracil (also called 5-fluorouracil or 5-FU).

If you can’t have or don’t want cancer treatment

You may want to consider a type of care to make you feel better without treating the cancer itself. This may be because the cancer treatments don’t work anymore, they’re not likely to improve your condition or they may cause side effects that are hard to cope with. There may also be other reasons why you can’t have or don’t want cancer treatment.

Talk to your healthcare team. They can help you choose care and treatment for advanced cancer.

Clinical trials

Talk to your doctor about clinical trials open to people with hypopharyngeal cancer in Canada. Clinical trials look at new ways to prevent, find and treat cancer. Find out more about clinical trials.

Expert review and references

  • American Cancer Society. Treating Laryngeal and Hypopharyngeal Cancer. 2021.
  • Bozec A, Poissonnet G, Dassonville O, Culie D. Current therapeutic strategies for patients with hypopharyngeal carcinoma: oncologic and functional outcomes. Journal of Clinical Medicine. 2023: 12(3): 1237.
  • PDQ® Adult Treatment Editorial Board. Hypopharyngeal Cancer Treatment (Adult) (PDQ®) – Health Professional. Bethesda, MD: National Cancer Institute; 2019: https://www.cancer.gov/.
  • National Comprehensive Cancer Network . NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancer Version 2.2023 . 2023: https://www.nccn.org/guidelines/category_1.
  • Machiels JP, Leemans CR, & Golusinski W. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO clinical practices guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2020: 31(11): 146201475.
  • Mendenhall WM, Dziegielewski PT, Dunn LA. Cancer of the larynx and hypopharynx. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, chapter 25, https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society